Hydroxychloroquine versus Remdesivir

Senegal's amazing success with coronavirus

$1 testing kit, testing everyone, if test positive given chloroquine right away, use 3D printing machine to make ventilators for $60

Only 2 deaths in Senegal reported a month into the outbreak.

Highest rate of recovery in Africa and the 3rd in the world - ahead of U.S.

Dr. Eric Berg, May 3, 2020, 5 min video (well worth the watch)

https://youtu.be/iBma_0oAiMI

Timestamps

0:10 A big mistake by the World Health Organization

1:13 Remdesivir versus hydroxychloroquine

2:00 A new study

2:48 Senegal - An amazing story on hydroxychloroquine

Description box

A big mistake was made by the World Health Organization when they sent this study to various publications. There was a rush to publish the study right away because of the success of remdesivir, and the wrong study was accidentally sent.

In the study that was sent, there was not an association with statistically significant clinical benefits with remdesivir.

The study that they wanted to publish only showed a moderate improvement in recovery time. Remdesivir is also an expensive drug.

The media has sparked excitement over remdesivir, but is ignoring hydroxychloroquine.

A new study that was done using hydroxychloroquine and an antibiotic showed that 91.7% of the patients that were tested for COVID-19, in 10 days did not test positive for COVID-19. The mortality rate was 0.5%, with no cardiac toxicity. Hydroxychloroquine is a very inexpensive drug.